BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1606289)

  • 1. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
    van Wersch JW; van Mourik-Alderliesten CH; Coremans A
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
    van Wersch JW; de Vries-Hanje JC; Oosterbos C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
    Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
    Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of markers of coagulation activation in patients under oral anticoagulation at different levels.
    van Wersch JW; van Mourik-Alderliesten CH; Coremans A
    Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):461-6. PubMed ID: 1445959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
    Leroy-Matheron C; Gouault-Heilmann M
    Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia.
    Bounameaux H; Righetti A; de Moerloose P; Bongard O; Reber G
    Thromb Res; 1992 Jan; 65(1):27-32. PubMed ID: 1604440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
    Jafri SM; Mammen EF; Masura J; Goldstein S
    Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolysis in smoking and nonsmoking pregnant women.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Br J Obstet Gynaecol; 1996 Aug; 103(8):789-94. PubMed ID: 8760709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
    de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma.
    Iversen LH; Thorlacius-Ussing O
    Thromb Res; 1996 Jan; 81(2):253-61. PubMed ID: 8822140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy?
    Barcellona D; Biondi G; Mameli G; Marongiu F
    Int J Clin Lab Res; 1997; 27(1):76-8. PubMed ID: 9144033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-Chloromethylketone (PPACK).
    Rahr HB; Sørensen JV; Danielsen D
    Thromb Res; 1994 Mar; 73(5):279-84. PubMed ID: 8016814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
    Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation parameters in retinal arterial occlusion.
    Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
    Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis in newborns of smoking and nonsmoking mothers.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.